Home / Azacitidine / United States
US ATC L01BC07 · updated 2 Nov 2026
Azacitidine shortage in United States
Is there an Azacitidine shortage in United States?
Yes. As of 2 Nov 2026, 9 Azacitidine products are reported short in United States, the first since 18 Dec 2020. No return date has been given. Main reason: not stated.
Also short in Italy, Spain, Ireland, Switzerland, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Dr. Reddy's Laboratories, Inc. | 18 Dec 2020 | not given | Not stated |
| US | Azacitidine, Injection, 100 mg (NDC 72485-201-01) limited | Armas Pharmaceuticals Inc | 18 Dec 2020 | not given | Other |
| US | Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Hikma Pharmaceuticals USA, Inc. | 18 Dec 2020 | not given | Increased demand Demand increase for the drug |
| US | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) discontinuation | Fresenius Kabi USA, LLC | 18 Dec 2020 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Meitheal Pharmaceuticals, Inc. | 18 Dec 2020 | not given | Not stated |
| US | Vidaza, Injection, 100 mg (NDC 59572-102-01) | Bristol Myers Squibb Co. | 18 Dec 2020 | not given | Not stated |
| US | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Accord Healthcare Inc. | 21 Dec 2020 | not given | Not stated |
| US | Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Teva Pharmaceuticals USA, Inc. | 22 Dec 2020 | not given | Other |
| US | Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Eugia US LLC | 22 Dec 2020 | not given | Increased demand Demand increase for the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).